These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15279604)

  • 21. New therapeutic targets revealed through investigations of innate immunity.
    Ulevitch RJ
    Crit Care Med; 2001 Jul; 29(7 Suppl):S8-12. PubMed ID: 11445726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses.
    Schröder NW; Heine H; Alexander C; Manukyan M; Eckert J; Hamann L; Göbel UB; Schumann RR
    J Immunol; 2004 Aug; 173(4):2683-91. PubMed ID: 15294986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LPS, TLR4 and infectious disease diversity.
    Miller SI; Ernst RK; Bader MW
    Nat Rev Microbiol; 2005 Jan; 3(1):36-46. PubMed ID: 15608698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms involved in the pathogenesis of septic shock.
    López-Bojórquez LN; Dehesa AZ; Reyes-Terán G
    Arch Med Res; 2004; 35(6):465-79. PubMed ID: 15631870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B.
    Jiang Q; Akashi S; Miyake K; Petty HR
    J Immunol; 2000 Oct; 165(7):3541-4. PubMed ID: 11034352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.
    Kim SJ; Kim HM
    BMB Rep; 2017 Feb; 50(2):55-57. PubMed ID: 28115037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4.
    Pålsson-McDermott EM; O'Neill LA
    Immunology; 2004 Oct; 113(2):153-62. PubMed ID: 15379975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.
    Tapping RI; Akashi S; Miyake K; Godowski PJ; Tobias PS
    J Immunol; 2000 Nov; 165(10):5780-7. PubMed ID: 11067937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha.
    Ruemmele FM; Beaulieu JF; Dionne S; Levy E; Seidman EG; Cerf-Bensussan N; Lentze MJ
    Gut; 2002 Dec; 51(6):842-8. PubMed ID: 12427787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors.
    Lien E; Ingalls RR
    Crit Care Med; 2002 Jan; 30(1 Suppl):S1-11. PubMed ID: 11782555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
    Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
    J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2.
    Girard R; Pedron T; Uematsu S; Balloy V; Chignard M; Akira S; Chaby R
    J Cell Sci; 2003 Jan; 116(Pt 2):293-302. PubMed ID: 12482915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor cluster formation during activation by bacterial products.
    Triantafilou M; Triantafilou K
    J Endotoxin Res; 2003; 9(5):331-5. PubMed ID: 14577851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial responses to endotoxins and Gram-negative bacteria.
    Heumann D; Roger T
    Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
    Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
    J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity.
    Supajatura V; Ushio H; Nakao A; Akira S; Okumura K; Ra C; Ogawa H
    J Clin Invest; 2002 May; 109(10):1351-9. PubMed ID: 12021251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
    Shinohara H; Inoue A; Toyama-Sorimachi N; Nagai Y; Yasuda T; Suzuki H; Horai R; Iwakura Y; Yamamoto T; Karasuyama H; Miyake K; Yamanashi Y
    J Exp Med; 2005 Feb; 201(3):333-9. PubMed ID: 15699069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogen recognition with Toll-like receptors.
    Kawai T; Akira S
    Curr Opin Immunol; 2005 Aug; 17(4):338-44. PubMed ID: 15950447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1.
    Siedlar M; Frankenberger M; Benkhart E; Espevik T; Quirling M; Brand K; Zembala M; Ziegler-Heitbrock L
    J Immunol; 2004 Aug; 173(4):2736-45. PubMed ID: 15294992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.